uniQure’s regulatory progress sparks optimism for ‘desperate’ Huntington’s space
BioSpace
Thu, 06/5/25 - 10:01 pm
uniQure
Huntington's disease
AMT-130
gene therapy
Newly proposed EU drug regulations a 'missed opportunity' to support innovation, industry says
Fierce Pharma
Thu, 06/5/25 - 09:58 pm
Europe
innovation
regulatory
EFPIA
Cullinan doubles down on bispecifics for autoimmune disease with Genrix deal
BioPharma Dive
Thu, 06/5/25 - 09:56 pm
Cullinan Oncology
autoimmune diseases
T cell engagers
Genrix Bio
US COVID vaccine recommendations sow confusion among doctors, insurers
MSN/Reuters
Thu, 06/5/25 - 09:54 pm
HHS
Robert F Kennedy Jr.
COVID-19
vaccines
US Health Secretary Kennedy looks to fast-tracking approvals for rare disease drugs
Yahoo/Reuters
Thu, 06/5/25 - 09:52 pm
HHS
Robert F Kennedy Jr.
FDA
fast track
Rare Diseases
June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Thu, 06/5/25 - 11:44 am
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Stat
Thu, 06/5/25 - 11:33 am
GLP-1 agonists
diabetes
age-related macular degeneration
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
BioPharma Dive
Thu, 06/5/25 - 11:30 am
ASCO 2025
cancer
oncology
bispecific antibodies
funding
breast cancer
Incyte’s Zynyz Wins FDA Approval as Single and Combo Therapy for Anal Cancer
Xtalks
Thu, 06/5/25 - 11:11 am
Incyte
Zynyz
anal cancer
FDA
Chasing Sarepta, RegenXBio links DMD gene therapy to improved outcomes
Fierce Biotech
Thu, 06/5/25 - 11:01 am
Regenxbio
DMD
gene therapy
Sarepta Therapeutics
Corcept unveils promising survival data from failed phase 2 ALS trial
Fierce Biotech
Thu, 06/5/25 - 09:59 am
Corcept Therapeutics
ALS
clinical trials
dazucorilant
Newsweek acquires Adprime, a healthcare-focused ad platform
Citybiz
Thu, 06/5/25 - 09:57 am
M&A
pharma advertising
Newsweek
Adprime
Ascletis’s daily acne tablet set for China review after Phase III win
Clinical Trials Arena
Thu, 06/5/25 - 09:49 am
Ascletis
China
clinical trials
denifanstat
acne
Daiichi Sankyo struck gold with ‘ADC’ cancer drugs. Its new CEO has to figure out what’s next.
BioPharma Dive
Thu, 06/5/25 - 09:46 am
ASCO 2025
Daiichi Sankyo
antibody-drug conjugates
Hiroyuki Okuzawa
Enhertu
Datroway
Questions swirl over who's running the CDC
Axios
Thu, 06/5/25 - 09:44 am
CDC
HHS
MAHA
Robert F Kennedy Jr.
FDA’s Elsa AI is here, and the industry has questions
Pharma Voice
Thu, 06/5/25 - 09:42 am
FDA
artificial intelligence
drug reviews
Elsa
Has mRNA delivered a breakthrough in quest for HIV cure?
Pharmaphorum
Thu, 06/5/25 - 09:40 am
MRNA
HIV
Merck gains U.S. patent office support in Keytruda dispute
MSN/Seeking Alpha
Wed, 06/4/25 - 10:46 pm
Merck
Keytruda
Halozyme Therapeutics
patents
legal
Biotech funding plummets as Trump policies unnerve investors: Jefferies
BioPharma Dive
Wed, 06/4/25 - 10:44 pm
biotech
funding
Donald Trump
investors
Medicare negotiations underway to lower prices for next batch of drugs
NPR
Wed, 06/4/25 - 10:42 pm
drug pricing
Medicare
Inflation Reduction Act
Novo Nordisk
Amgen

Pages